The present study aimed to investigate the difference in major adverse cardiac events (MACE) at 12 months in patients with coronary bifurcation lesions after double kissing double crush (DK crush) or provisional stenting (PS) techniques.
Objectives
The present study aimed to investigate the difference in major adverse cardiac events (MACE) at 12 months in patients with coronary bifurcation lesions after double kissing double crush (DK crush) or provisional stenting (PS) techniques.
Background
Provisional side branch (SB) stenting is preferable to DK crush because it has been associated with fewer complications. It is unknown which strategy would provide the best results.
Methods
From April 2007 to June 2009, 370 unselected patients with coronary bifurcation lesions from 7 Asian centers were randomly assigned to either the DK or the PS group. Additional SB stenting in PS was required if final results were suboptimal. The primary end point was the occurrence of MACE at 12 months, including cardiac death, myocardial infarction, or target vessel revascularization (TVR). Secondary end point was the angiographic restenosis at 8 months.
Results
There were 3 procedural occlusions of SB in the PS group. At 8 months, angiographic restenosis rates in the main vessel and SB were significantly different between the DK (3.8% and 4.9%) and the PS groups (9.7% and 22.2%, p ϭ 0.036 and p Ͻ 0.001, respectively). Additional SB stenting in the PS group was required in 28.6% of lesions. TVR was 6.5% in the DK group, occurring significantly less often than in the PS group (14.6%, p ϭ 0.017). There were nonsignificant differences in MACE and definite stent thrombosis between the DK (10.3% and 2.2%) and PS groups (17.3%, and 0.5%, p ϭ 0.070 and p ϭ 0.372, respectively).
Conclusions
DK crush was associated with a significant reduction of TLR and TVR in this unselected patient population. However, there was no significant difference in MACE between DK and the PS groups. Percutaneous coronary intervention for coronary bifurcation lesions still remains a hotly debated topic (1) . Several studies (2) (3) (4) have concluded that stenting the main vessel (MV) with provisional stenting (PS) of side branches (SB) is preferable in the great majority of bifurcation lesions. However, the difference in study design does not allow us to translate these studies into everyday practice. As a result, we designed this prospective, randomized DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial to address the clinical relevance of double kissing double crush (DK crush) and PS in our "unselected" patient population.
Methods
Patient selection. The DKCRUSH-II study was conducted in 7 Asian centers after the protocol was approved by the ethics committee, and signed informed consent was obtained from all patients.
Patients Ն18 years of age with a diagnosis of documented silent ischemia, angina, or acute myocardial infarction (AMI) (Ͻ12 h proceeding to an emergent percutaneous coronary intervention procedure) after the restoration of blood flow in 2 branches, were considered eligible for enrollment. Patients with chronic total occlusion in the MV or SB immediately after successful recanalization, and unprotected distal left main bifurcation lesions involving both ostia of the left anterior descending and left circumflex coronary arteries, without chronic total occlusion in the right coronary artery, were also enrolled. An additional eligibility criterion was the presence of only 1 coronary bifurcation lesion (Medina [5] classification 1,1,1 and 0,1,1) per patient, defined as a diameter stenosis of Ͼ50% in both vessels with a reference vessel diameter between 2.5 and 4.0 mm by visual estimation. The maximum treatable lesion length by visual estimation for each individual branch had to be completely covered by 2 EXCEL stents (JW Medical System, Weihai, China) (6) .
Exclusion criteria included liver dysfunction, expected lifespan Ͻ12 months, heavy calcification requiring rotational atherectomy, pregnancy, contraindication, or suspected intolerance to one of the study drugs.
Procedure. Patients were randomly assigned in a 1:1 ratio to the DK crush (DK group) or the PS group. DK crush, as described previously (7), was performed as follows: stenting SB, balloon crush, first kissing balloon inflation, stenting MV, and final kissing balloon inflation (FKBI). Another key step in the procedure is the alternative inflation with a noncompliant balloon at high pressure (Ն16 atm) for the SB before each kissing. In the PS group, a "safety" wire prior to MV stent placement was used in all cases. Criteria for treatment of SB following MV stent placement were: diameter stenosis Ͼ50%, dissection type ϾB, or decreased Thrombolysis In Myocardial Infarction (TIMI) flow. If balloon dilation was not successful, then the T stent technique was performed, followed by FKBI. Intravascular ultrasound pre-dilation and the administration of glycoprotein IIb/ IIIa inhibitors were left to the operator's discretion.
All patients were pretreated with aspirin and clopidogrel. A 300-mg loading dose of clopidogrel was administered before the index procedure if patients were not pretreated. Intravenous unfractionated heparin was used to maintain an activated clotting time between 250 and 300 s through the whole procedure. Total creatine kinase (CK) and CK-MB were dynamically measured until 72 h post-procedure. After discharge, aspirin therapy was continued indefinitely (100 mg/day for life), and clopidogrel (75 mg/day) was continued for at least 12 months. Follow-up. Clinical follow-up was performed with visits or telephone contact at 1, 6, 8, and 12 months. Adverse events were monitored throughout the entire study period. Follow-up coronary angiography was scheduled at 8 months after the indexed procedure unless clinical reasons indicated earlier.
Quantitative coronary angiographic measurements. Matched orthogonal views were used for quantitative coronary analysis (QCA) before, post-procedure, and at follow-up after intracoronary injection of nitroglycerin (ϳ100 to 200 g). Angiograms were analyzed offline with a validated automated edge-detection coronary bifurcation system (CAAS version 5.7, Pie Medical Imaging, Maastricht, the Netherlands). Vessel segments involving bifurca- .46 years) with true bifurcation lesions were enrolled and randomly assigned to the DK (n ϭ 185) and PS (n ϭ 185) groups. Baseline clinical and lesion characteristics (including the number of diseased vessels, lesion location, stratification of lesions, and TIMI flow grade 0 to 2) were well matched between the 2 groups (Tables 1 and 2 ). Procedural characteristics. In the PS group, 121 (65.4%) SB received balloon angioplasty only, 11 (5.9%) SB did not receive any therapy, and in 53 (28.6%) SB, additional stents were required. A significant reduction in angiographic success was observed in the SB between the DK and PS groups (p ϭ 0.007) ( Table 3) . The procedural time, total fluoroscopy, and contrast volume in the DK group were nonsignificant compared with the PS group. KUS was more frequently in PS (25.4%) group, compared with 8.1% in DK group (p Ͻ 0.001).
QCA analysis. Repeat angiogram at 8 months (average 249.51 Ϯ 52.41 days) was available in 339 (91.6%) patients. There were no significant differences in terms of the baseline characteristics between the 2 groups (Table 4) . DK crush was associated with increased post-stenting MLD in the MV, POC, and SB (Tables 4 and 5 ). This resulted in a significant reduction of diameter stenosis (DS), an increase in acute gain, and an increased net gain in POC and SB relative to the PS group, with the exception of the MV. The overall restenosis rates in the MV and SB were 3.8% and 4.9% in the DK group, respectively, compared with 9.7% (p ϭ 0.036) and 22.2% (p Ͻ 0.001) in the PS group. Values are mean Ϯ SD or n (%). DS ϭ diameter stenosis; MLD ϭ minimal lumen diameter; QCA ϭ quantitative coronary analysis; RVD ϭ reference vessel diameter; other abbreviations as in Table 1 .
QCA in Entire Cohort of Patients
Quantitative Coronary Analysis for POC Area Values are mean Ϯ SD or n (%).
Abbreviations as in Tables 1 and 4 .
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Restenosis at the SB ostium and POC in the PS and DK groups were as follows: 18.4% versus 3.8% (p Ͻ 0.001), and 19.5% versus 4.3% (p Ͻ 0.001). Class I ISR in MV and SB were seen in 82% and 88%, with Class II, III, and IV in 11% and 6%, 3% and 2%, and 4% and 4%, respectively Clinical outcome. SB occlusion immediately after MV stent placement occurred 3 times (1.6%) in the PS group (Table 6 ). There were no significant differences in procedural success rate and cumulative MACE and ST rate at 6 months between the 2 groups (Table 6) . At 12 months, the rates of cardiac death and MI in the DK and PS groups were comparable. TLR in the DK group (4.3%) occurred significantly less often than in the PS group (13.0%, p ϭ 0.005) (Fig. 1A) , with clinically driven TLR in Values are n (%). IABP ϭ intra-aortic balloon pumping; MACE ϭ major adverse cardiac event(s); TLR ϭ target lesion revascularization; TVR ϭ target vessel revascularization; other abbreviations as in Table 1 .
Clinical Outcome
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Chen 22, 2011:914-20 29 (7 in the DK, 22 in the PS groups), and ischemia-driven TLR in 3 (1 in the DK and 2 in PS groups) patients. This translated into an increased rate of TVR in the PS group (14.6% vs. 6.5%, p ϭ 0.017) (Fig. 1B) . However, there was no difference in the cumulative MACE between the DK (10.3%) versus PS (17.3%, p ϭ 0.070) groups (Fig. 1C) . The overall and definite ST in DK were 2.7% and 2.2%, all nonsignificant with respect to PS group (1.1% and 0.5%, respectively). The timing, baseline, and procedural characteristics of patients in whom ST occurred are summarized in Table 7 .
Discussion
The major findings of the present study were: 1) 28.6% of patients in the PS group were transferred to the 2-stent subgroup; and 2) DK crush had a lower rate of TLR and TVR at 12 months in this unselected patient population, with 91.6% having repeat angiograms at 8 months.
Comparison with previous studies. The rate of PS with SB stenting varied mainly depending on the study design. When stenting of the SB was limited to the cases with severely impaired blood flow (2, 12) , this rate was around ϳ2% to 4%. If residual stenosis Ͼ50% was considered as one of the criteria, stenting the SB was required in 22% (13) (17) (18) (19) . The quality of FKBI should not be ignored when crush stenting was used. Conceptually, classical crush with 2-step kissing is easily confused with DK crush. The former method introduces the first kissing inflation by the MV balloon and side stent without rewiring the SB, resulting in no real difference from the original crush. DK crush, focusing on the performance and quality of each kissing inflation using a noncompliant balloon in the SB, was associated with a significant reduction of TVR in the MV and SB (19, 20) . On the other hand, the routine use of FKBI after the 1-stent technique for simple bifurcations would not carry any advantage over that without FKBI (21) , but without functional assessment (22) . The present study reported a 2.6-fold increase of ISR in MV by PS, which might reflect the importance of the quality of FKBI even after the 1-stent technique.
Comparison of safety end points. The 2-stent technique seems also to have a detrimental impact on the occurrence of ST (1, 4, 10, 23) , varying from 0.2% to 4.5%. However, the presence of procedural SB occlusion in the PS group in the DKCRUSH-II and CACTUS studies indicated that a jailed wire in the SB could not improve the procedural safety in bigger SB with a heavy plaque burden. The clinical implication of the present study is that DK crush stenting would be superior to PS for complex/highrisk bifurcation lesions. Study limitations. The present study reported clinical results at 12 months. We could not address the difference in clinical outcome when follow-up was extended. Another limitation is the lack of functional assessment by fractional flow reserve. Finally, sample sizes were probably inadequate for the analysis of ST risk in 2 groups.
Patients With ST
Conclusions
This DKCRUSH-II study for unselected patients with coronary bifurcation lesions indicates that implantation of sirolimus-eluting stents was associated with a lower rate of overall restenosis in the MV. DK crush reduced the occurrence of restenosis in both the MV and SB, resulting in a reduction of TLR and TVR.
